Company intelligence / Profile preview
Artin Immunology
Irvine, California, United Statesartinimmunology.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Artin Immunology is a preclinical-stage biotechnology company focused on developing innovative immunotherapies for autoimmune diseases and cancer. The company utilizes a proprietary platform to create antigen-specific T-cell therapies designed to restore immune balance and provide long-lasting remission. By targeting the root causes of immune dysregulation, Artin Immunology aims to transform the treatment landscape for chronic conditions such as Type 1 Diabetes and Multiple Sclerosis. The company is headquartered in Irvine, California, and is led by a team of experts in immunology and cell engineering.
- Therapeutic areas
- OncologyEndocrinologyImmunologyNeurology
- Modalities
- Cell therapyT cell therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Artin Immunology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Artin Immunology.